SCHEMBL30866622

SCHEMBL30866622

CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(O)cc4)cc23)c1F

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 2/20 0.87
RIPK2 O43353 1/20 0.87
ABCB11 O95342 1/20 0.87
EGFR P00533 1/20 0.87
KRAS P01116 1/20 0.87
RAF1 P04049 1/20 0.87
PGR P06401 1/20 0.87
RET P07949 1/20 0.87
CHRM2 P08172 1/20 0.87
ADORA3 P0DMS8 1/20 0.87
ARAF P10398 1/20 0.87
CHRM1 P11229 1/20 0.87
CHRM3 P20309 1/20 0.87
FECH P22830 1/20 0.87
KDR P35968 1/20 0.87
MAP2K2 P36507 1/20 0.87
TGFBR2 P37173 1/20 0.87
NEK2 P51955 1/20 0.87
MAP2K1 Q02750 1/20 0.87
TNK2 Q07912 1/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL298373 1.00 BRAF (0.87) BRAFRIPK2ABCB11EGFRKRAS
SCHEMBL298927 0.94 BRAF (0.89) BRAFRIPK2ABCB11EGFRKRAS
Vemurafenib SCHEMBL29355460 0.93 BRAF (1.00) BRAFRIPK2ABCB11EGFRKRAS
SCHEMBL29898578 0.93 BRAF (0.87) BRAFRIPK2ABCB11EGFRKRAS
SCHEMBL855840 0.93 BRAF (0.87) BRAFRIPK2ABCB11EGFRKRAS
SCHEMBL12891936 0.93 BRAF (1.00) BRAFRIPK2ABCB11EGFRKRAS
Vemurafenib SCHEMBL29356185 0.93 BRAF (1.00) BRAFRIPK2ABCB11EGFRKRAS
Vemurafenib SCHEMBL298931 0.93 BRAF (1.00) BRAFRIPK2ABCB11EGFRKRAS
SCHEMBL20294636 0.92 BRAF (1.00) BRAFRIPK2ABCB11EGFRKRAS
SCHEMBL7868333 0.92 CYP2C19 (0.86) BRAFRIPK2ABCB11EGFRKRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112424201-B Protein kinase inhibitors that promote liver regeneration or reduce or prevent hepatocyte death 海帕瑞吉尼克斯股份有限公司 2024-04-02 CN disclosed